Editorial Policy for the International Journal of Therapeutic Innovation

The International Journal of Therapeutic Innovation (IJTI) is committed to promoting high-quality research and scholarly work in the fields of medical and pharmaceutical sciences. As an open-access journal, IJTI provides a dynamic platform for researchers, academicians, and practitioners to share advancements and foster innovation in these disciplines. The editorial policy outlined below reflects the core principles and guidelines that govern the publication process at International Journal of Therapeutic Innovation:

Scope: The International Journal of Therapeutic Innovationinvites submissions of original research articles, reviews, case studies, commentaries, and perspectives across diverse areas of medical and pharmaceutical sciences. Key disciplines include, but are not limited to, clinical research, drug discovery and development, pharmacology, toxicology, pharmacovigilance, pharmaceutical technology, medical education, and healthcare management.

Quality Standards: The International Journal of Therapeutic Innovation invites submissions of original research articles, reviews, case studies, commentaries, and perspectives in a broad range of medical and pharmaceutical science disciplines. These include, but are not limited to, clinical research, drug discovery and development, pharmacology, toxicology, pharmacovigilance, pharmaceutical technology, medical education, and healthcare management.

International Journal of Therapeutic Innovation is committed to upholding rigorous quality standards. All submitted manuscripts undergo a comprehensive double-blind peer-review process conducted by experts in the relevant fields. Submissions are evaluated based on scientific validity, originality, clarity, and the significance of their contributions to the field.

Open Access: The International Journal of Therapeutic Innovation is an open-access publication, ensuring that all articles are freely available to readers worldwide without subscription fees or paywalls. This approach maximizes visibility, accessibility, and dissemination of research, fostering broader impact and engagement within the scientific community and beyond.

Authorship and Ethical Considerations: The International Journal of Therapeutic Innovation strictly follows internationally recognized guidelines for authorship and publication ethics. All authors are required to have made significant contributions to the research and to consent to the manuscript’s publication. The journal maintains a zero-tolerance policy toward plagiarism, data fabrication, and other unethical practices. Additionally, authors are encouraged to disclose any potential conflicts of interest related to their research or affiliations.

Copyright and Licensing: Authors retain the copyright to their published work in the International Journal of Therapeutic Innovation. The journal operates under a Creative Commons Attribution License (CC BY), allowing others to distribute, remix, adapt, and build upon the work, provided the original source is properly credited.

Editorial Independence: The International Journal of Therapeutic Innovation upholds editorial independence, ensuring that manuscript acceptance or rejection decisions are made solely based on the scientific merit of the work. The editorial team, reviewers, and editors are dedicated to impartial evaluations and actively avoid any conflicts of interest that could compromise the integrity of the publication process.

Correction and Retraction: The International Journal of Therapeutic Innovation is committed to maintaining the accuracy and integrity of all published articles. Should significant errors or instances of misconduct be identified after publication, the journal will take appropriate actions—such as issuing corrections, errata, or retractions—in accordance with established guidelines and best practices.

Journal Archiving: The International Journal of Therapeutic Innovation recognizes the importance of preserving research outputs for future reference. To ensure long-term accessibility and availability, the journal employs digital archiving services and platforms.

Editorial Updates: The editorial policy of the International Journal of Therapeutic Innovation is periodically reviewed and updated to reflect evolving standards and best practices in scientific publishing. Any changes will be communicated transparently on the journal’s website.

The journal encourages authors, researchers, and readers to familiarize themselves with these policies to ensure a smooth and efficient publication process. International Journal of Therapeutic Innovation remains committed to facilitating the dissemination of valuable research and advancing the fields of medical and pharmaceutical sciences.

For detailed submission guidelines and instructions, please refer to the "Instructions for Authors" section on the International Journal of Therapeutic Innovation website:  https://ijtinnovation.com/introduction-to-author